Back to the Top
We are considering sequential BE testing for highly variable compounds.
Has anyone any regulator insight into its acceptability. I know it
seems OK under ICH E9
Dr Ifty Khan
Manager Phase I Clinical Research
Merck Generics UK
EN6 1 AG
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "Sequential BE Methods" as the subject
Support PharmPK by using the
Copyright 1995-2011 David W. A. Bourne (email@example.com)